'One-Party Science' Poses Threat To Scientists' Intellectual Freedom

Intellectual Freedom For the past decade or so, as many people are aware, my research has focused on assessing racial differences as manifested in brain size and intelligence. Startling and, I have come to understand, alarming to many people is my challenge to the prevailing view that if all people were treated the same, most race differences would disappear. I have found, for example, that Asians and Africans average at opposite

Written byJ Rushton
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Intellectual Freedom

For the past decade or so, as many people are aware, my research has focused on assessing racial differences as manifested in brain size and intelligence. Startling and, I have come to understand, alarming to many people is my challenge to the prevailing view that if all people were treated the same, most race differences would disappear. I have found, for example, that Asians and Africans average at opposite ends of a continuum ranging over 60 anatomical and social variables, with Europeans intermediate. Based on my studies, I have proposed a gene-based evolutionary theory of racial patterns.

I can understand why, for nonscientists, some of my findings have become an object of scorn; indeed, some critics believe that my research should be banned. And this is disturbing to me, of course. But of real concern is the behavior of many in the scientific community, who repress publication of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies